Intravitreal ranibizumab for choroidal neovascularization secondary to choroidal nevus.
OBJECTIVE
To describe a patient treated with ranibizumab for juxtafoveal choroidal neovascularization secondary to choroidal nevus.


METHODS
A 71-year-old man presented with juxtafoveal choroidal neovascularization secondary to choroidal nevus. Choroidal neovascularization was initially treated with a single intravitreal injection of ranibizumab.


RESULTS
The treatment was successful and best-corrected visual acuity improved from 20/50 to 20/25 and remained stable during 7 months. A recurrence was observed 9 months after initial treatment.


CONCLUSIONS
Ranibizumab seems to be an effective treatment for choroidal neovascularization secondary to choroidal nevus. However, late recurrence may occur.
From the *Centre Ophtalmologique d'Imagerie et de Laser, Paris, France; and †University Eye Clinic, Creteil, France.
Benjamin
B
Guigui
Eric H
EH
Souied
Salomon Yves
SY
Cohen